Abstract

Research Article

Amniotic Fluid Ischemia Modified Albumin as a Novel Prenatal Diagnostic Marker for Down Syndrome: A Prospective Case-Control Study

Suleyman Guven*, Erhan Huseyin Comert, Emine Seda Guvendag Guven, Bulent Demir and Deniz Karcaaltincaba

Published: 21 June, 2023 | Volume 6 - Issue 2 | Pages: 082-087

Aims: There is no study in the literature about ischemia-modified albumin (IMA) and hepatocyte growth factor (HGF) levels in amniotic fluid for Down syndrome cases. The aim of this study was to investigate the changes of IMA and HGF in Down syndrome cases at 16-20 weeks of gestation compared to normal fetuses.
Methods: For this prospective case-control study, following reaching the number of 20 women (study group) who had the prenatal diagnosis of Down syndrome, maternal and gestational age-matched pregnant women with normal constitutional karyotype were selected for the control group (n = 74) from the stored amniotic fluid samples. 
Results: Mean women and gestational ages were comparable between the two groups. Amniotic fluid IMA (1.32 ± 0.13 vs. 1.11 ± 0.11 ABSU, respectively, p < 0.001) and HGF (2743.53 ± 1389.28 vs. 2160.12 ± 654.63 pg/mL, respectively, p = 0.008). Levels were significantly higher in pregnant women having Down syndrome fetuses compared with women having normal fetuses. The amniotic fluid IMA levels for the diagnosis of Down syndrome, and the sensitivity and specificity were calculated as 95.0% and 71.6% for the limit value 1.171 cm3, respectively. 
Conclusion: In cases with suspected Down syndrome, the diagnosis of Down Syndrome may be made in approximately 1 hour with high sensitivity and specificity by measuring the IMA level in the amniotic fluid sample taken for fetal karyotyping.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001133 Cite this Article Read Full Article PDF

Keywords:

Amniocentesis; Biochemical test; Down Syndrome; Prenatal screening

References

  1. Cuckle H, Benn P. Review of epidemiological factors (other than maternal age) that determine the prevalence of common autosomal trisomies. Prenat Diagn. 2021 Apr;41(5):536-544. doi: 10.1002/pd.5822. Epub 2020 Sep 21. PMID: 32895968.
  2. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020 Oct;136(4):e48-e69. doi: 10.1097/AOG.0000000000004084. PMID: 32804883.
  3. Loane M, Morris JK, Addor MC, Arriola L, Budd J, Doray B, Garne E, Gatt M, Haeusler M, Khoshnood B, Klungsøyr Melve K, Latos-Bielenska A, McDonnell B, Mullaney C, O'Mahony M, Queisser-Wahrendorf A, Rankin J, Rissmann A, Rounding C, Salvador J, Tucker D, Wellesley D, Yevtushok L, Dolk H. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet. 2013 Jan;21(1):27-33. doi: 10.1038/ejhg.2012.94. Epub 2012 Jun 20. PMID: 22713804; PMCID: PMC3522199.
  4. Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, Tomlinson MW, Pereira L, Spitz JL, Hollemon D, Cuckle H, Musci TJ, Wapner RJ. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015 Apr 23;372(17):1589-97. doi: 10.1056/NEJMoa1407349. Epub 2015 Apr 1. PMID: 25830321.
  5. Tabibzadeh S. Cytokines and the hypothalamic-pituitary-ovarian-endometrial axis. Hum Reprod. 1994 May;9(5):947-67. doi: 10.1093/oxfordjournals.humrep.a138621. PMID: 7929746.
  6. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993 Jul;14(7):353-6. doi: 10.1016/0167-5699(93)90235-D. PMID: 8363725.
  7. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today. 1997 Oct;18(10):478-82. doi: 10.1016/s0167-5699(97)01127-4. PMID: 9357139.
  8. Nanji AA, Khwaja S, Tahan SR, Sadrzadeh SM. Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J Pharmacol Exp Ther. 1994 Jun;269(3):1280-5. PMID: 8014871.
  9. Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies. Acta Obstet Gynecol Scand. 2009;88(4):479-82. doi: 10.1080/00016340902777517. PMID: 19235558.
  10. Guven S, Karahan SC, Kandemir O, Ucar U, Cora AO, Bozkaya H. Occult inflammation and/or ischemia may be responsible for the false positivity of biochemical Down syndrome screening test. J Perinat Med. 2010 Jul;38(4):367-71. doi: 10.1515/jpm.2010.062. PMID: 20297899.
  11. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem. 2001 Jan;268(1):42-7. doi: 10.1046/j.1432-1327.2001.01846.x. PMID: 11121100.
  12. Karahan SC, Koramaz I, Altun G, Uçar U, Topbaş M, Menteşe A, Kopuz M. Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study. Eur Surg Res. 2010;44(1):30-6. doi: 10.1159/000262324. Epub 2009 Dec 1. PMID: 19955769.
  13. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS; Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem. 2005 May;51(5):810-24. doi: 10.1373/clinchem.2004.046292. Epub 2005 Mar 17. PMID: 15774573.
  14. Santhanam U, Avila C, Romero R, Viguet H, Ida N, Sakurai S, Sehgal PB. Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine. 1991 Mar;3(2):155-63. doi: 10.1016/1043-4666(91)90037-e. PMID: 1888885.
  15. Tsunoda H, Tamatani T, Oomoto Y, Hirai Y, Kasahara T, Iwasaki H, Onozaki K. Changes in interleukin 1 levels in human amniotic fluid with gestational ages and delivery. Microbiol Immunol. 1990;34(4):377-85. doi: 10.1111/j.1348-0421.1990.tb01018.x. PMID: 2362563.
  16. Opsjłn SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol. 1993 Aug;169(2 Pt 1):397-404. doi: 10.1016/0002-9378(93)90096-2. PMID: 8362955.
  17. Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine. 1993 Jan;5(1):81-8. doi: 10.1016/1043-4666(93)90027-3. PMID: 7683506.
  18. Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, Syn HC. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 1995 Mar;172(3):960-70. doi: 10.1016/0002-9378(95)90028-4. PMID: 7892891.
  19. Oláh KS, Vince GS, Neilson JP, Deniz G, Johnson PM. Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term. J Reprod Immunol. 1996 Nov;32(1):89-98. doi: 10.1016/s0165-0378(96)00990-4. PMID: 8953522.
  20. Horibe N, Okamoto T, Itakura A, Nakanishi T, Suzuki T, Kazeto S, Tomoda Y. Levels of hepatocyte growth factor in maternal serum and amniotic fluid. Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):937-42. doi: 10.1016/0002-9378(95)90370-4. PMID: 7573273.
  21. Lieman-Hurwitz J, Dafni N, Lavie V, Groner Y. Human cytoplasmic superoxide dismutase cDNA clone: a probe for studying the molecular biology of Down syndrome. Proc Natl Acad Sci U S A. 1982 May;79(9):2808-11. doi: 10.1073/pnas.79.9.2808. PMID: 6211674; PMCID: PMC346295.
  22. Netto CB, Siqueira IR, Fochesatto C, Portela LV, da Purificação Tavares M, Souza DO, Giugliani R, Gonçalves CA. S100B content and SOD activity in amniotic fluid of pregnancies with Down syndrome. Clin Biochem. 2004 Feb;37(2):134-7. doi: 10.1016/j.clinbiochem.2003.09.010. PMID: 14725944.
  23. Baeteman MA, Mattei MG, Baret A, Gamerre M, Mattei JF. Immunoreactive SOD-1 in amniotic fluid, amniotic cells and fibroblasts from trisomy 21 fetus. Acta Paediatr Scand. 1985 Sep;74(5):697-700. doi: 10.1111/j.1651-2227.1985.tb10016.x. PMID: 2931942.
  24. de Haan JB, Wolvetang EJ, Cristiano F, Iannello R, Bladier C, Kelner MJ, Kola I. Reactive oxygen species and their contribution to pathology in Down syndrome. Adv Pharmacol. 1997;38:379-402. doi: 10.1016/s1054-3589(08)60992-8. PMID: 8895817.
  25. de Haan JB, Cristiano F, Iannello RC, Kola I. Cu/Zn-superoxide dismutase and glutathione peroxidase during aging. Biochem Mol Biol Int. 1995 May;35(6):1281-97. PMID: 7492966.
  26. de Haan JB, Newman JD, Kola I. Cu/Zn superoxide dismutase mRNA and enzyme activity, and susceptibility to lipid peroxidation, increases with aging in murine brains. Brain Res Mol Brain Res. 1992 Apr;13(3):179-87. doi: 10.1016/0169-328x(92)90025-7. PMID: 1593944.
  27. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - review and clinical implications. Clin Chem Lab Med. 2011 Feb;49(2):177-84. doi: 10.1515/CCLM.2011.037. Epub 2010 Nov 18. PMID: 21083441.
  28. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, Hill SA. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ. 2005 Jun 21;172(13):1685-90. doi: 10.1503/cmaj.045194. PMID: 15967971; PMCID: PMC1150260.
  29. Erdem SS, Yerlikaya FH, Çiçekler H, Gül M. Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis. Clin Chem Lab Med. 2012 Feb 14;50(8):1417-21. doi: 10.1515/cclm-2011-0794. PMID: 22868807.
  30. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers. 2008;24(6):311-7. doi: 10.1155/2008/784313. PMID: 18688079; PMCID: PMC3850615.
  31. Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem. 2004 Nov;50(11):2190-3. doi: 10.1373/clinchem.2004.034371. PMID: 15502098.
  32. Ohnishi Y, Yamashiro C, Yanagihara T, Hata T. Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth. Hum Reprod. 1999 Oct;14(10):2625-8. doi: 10.1093/humrep/14.10.2625. PMID: 10527998.
  33. Visiedo F, Bugatto F, Carrasco-Fernández C, Sáez-Benito A, Mateos RM, Cózar-Castellano I, Bartha JL, Perdomo G. Hepatocyte growth factor is elevated in amniotic fluid from obese women and regulates placental glucose and fatty acid metabolism. Placenta. 2015 Apr;36(4):381-8. doi: 10.1016/j.placenta.2015.01.199. Epub 2015 Feb 7. PMID: 25690371.
  34. Maraldi T, Beretti F, Guida M, Zavatti M, De Pol A. Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells. Stem Cells Transl Med. 2015 Jun;4(6):539-47. doi: 10.5966/sctm.2014-0266. Epub 2015 Apr 14. PMID: 25873747; PMCID: PMC4449098.
  35. Sahan OB, Gunel-Ozcan A. Hepatocyte Growth Factor and Insulin-like Growth Factor-1 based Cellular Therapies for Oxidative Stress Injury. Curr Stem Cell Res Ther. 2021;16(7):771-791. doi: 10.2174/1574888X16999201124153753. PMID: 33238860.
  36. Cheng W, Liu GP, Kong D, Huang W, Sun Y, Zhao D. Downregulation of miR-1224 protects against oxidative stress-induced acute liver injury by regulating hepatocyte growth factor. J Cell Biochem. 2019 Aug;120(8):12369-12375. doi: 10.1002/jcb.28502. Epub 2019 Mar 8. PMID: 30848506.
  37. Hirono K, Miura M, Kanegane H, Miyamoto M, Yoshimura N, Ichida F, Ito E, Miyawaki T. Hepatocyte growth factor in transient myeloproliferative disorder of Down syndrome. Pediatr Int. 2009 Oct;51(5):754-5. doi: 10.1111/j.1442-200X.2009.02897.x. PMID: 19799747.
  38. Douglas SD. Down syndrome: immunologic and epidemiologic associations-enigmas remain. J Pediatr. 2005 Dec;147(6):723-5. doi: 10.1016/j.jpeds.2005.09.002. PMID: 16356417.
  39. de Hingh YC, van der Vossen PW, Gemen EF, Mulder AB, Hop WC, Brus F, de Vries E. Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr. 2005 Dec;147(6):744-7. doi: 10.1016/j.jpeds.2005.07.022. PMID: 16356423.

Figures:

Similar Articles

Recently Viewed

  • A Rare Case of an Acquired Isolated Factor VII Deficiency was Discovered in a 23-Year-Old Female Patient
    Zahra Kmira*, Sassi Nedia, Ben Yahia Noura, Ben Sayed Nesrine, Greisha Ahmed, Mootameri Wided, Bouteraa Walid, Zaier Monia, Ben Youssef Yosra, Brahem Nejia, Haifa Regaieg and Khelif Abderrahim Zahra Kmira*, Sassi Nedia, Ben Yahia Noura, Ben Sayed Nesrine, Greisha Ahmed, Mootameri Wided, Bouteraa Walid, Zaier Monia, Ben Youssef Yosra, Brahem Nejia, Haifa Regaieg, Khelif Abderrahim. A Rare Case of an Acquired Isolated Factor VII Deficiency was Discovered in a 23-Year-Old Female Patient. J Hematol Clin Res. 2023: doi: 10.29328/journal.jhcr.1001025; 7: 025-028
  • Electronic and Thermo-Dynamical Properties of Rare Earth RE2X3 (X=O, S) Compounds: A Chemical Bond Theory
    Pooja Yadav, DS Yadav* and DV Singh Pooja Yadav, DS Yadav*, DV Singh. Electronic and Thermo-Dynamical Properties of Rare Earth RE2X3 (X=O, S) Compounds: A Chemical Bond Theory. Int J Phys Res Appl. 2024: doi: 10.29328/journal.ijpra.1001083; 7: 048-052
  • The Effect of Residence Time of No-tunneled Hemodialysis Catheters on Infection and Thrombosis Outcome. Identification of CVC’s Time Cut-off
    Luciano De Paola*, Mariantonia Panzino, Laura Saturno, Maria Antonietta Mascaro, Marco Vatrano, Federica De Paola, Citraro Maria Lucia, Bova Francesca, D’Onofrio Giuseppina and Giovanni Ruotolo Luciano De Paola*, Mariantonia Panzino, Laura Saturno, Maria Antonietta Mascaro, Marco Vatrano, Federica De Paola, Citraro Maria Lucia, Bova Francesca, D’Onofrio Giuseppina, Giovanni Ruotolo. The Effect of Residence Time of No-tunneled Hemodialysis Catheters on Infection and Thrombosis Outcome. Identification of CVC’s Time Cut-off. J Clini Nephrol. 2024: doi: 10.29328/journal.jcn.1001122; 8: 023-031
  • Effects of secondary hyperparathyroidism treatment on hemoglobin levels and erythropoietin doses in hemodialysis patients
    Carlo Massimetti*, Antonio Bellasi and Sandro Feriozzi Carlo Massimetti*,Antonio Bellasi,Sandro Feriozzi. Effects of secondary hyperparathyroidism treatment on hemoglobin levels and erythropoietin doses in hemodialysis patients. J Clini Nephrol. 2021: doi: 10.29328/journal.jcn.1001081; 5: 088-094
  • Strongyloides stercoralis and glomerular diseases: A case report
    Gabriel Ledesma*, Begoña Rivas, Cristina Vega, Gilda Carreño, Raquel Díaz, Ángel Gallegos, Verónica Mercado, Silvia Caldés, Yesika Amezquita, Yolanda Hernández, Rocío Echarri, Covadonga Hevia and Antonio Cirugeda Gabriel Ledesma*,Begoña Rivas,Cristina Vega,Gilda Carreño,Raquel Díaz,Ángel Gallegos,Verónica Mercado,Silvia Caldés,Yesika Amezquita,Yolanda Hernández,Rocío Echarri,Covadonga Hevia,Antonio Cirugeda. Strongyloides stercoralis and glomerular diseases: A case report. J Clini Nephrol. 2022: doi: 10.29328/journal.jcn.1001099; 6: 097-098

Read More

Most Viewed

Read More

Help ?